APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBERApyxMedical2025-12-12T19:42:06+00:00November 4, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN SKIN LAXITY PROCEDURES IN THE NECK AND SUBMENTAL REGIONApyxMedical2025-12-12T19:42:29+00:00October 14, 2019|Read More
APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR THE APYX PLASMA/RF HANDPIECEApyxMedical2025-12-12T19:43:03+00:00October 14, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON NOVEMBER 11, 2019ApyxMedical2025-12-12T19:43:26+00:00September 24, 2019|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER AND OCTOBERApyxMedical2025-12-12T19:43:47+00:00August 22, 2019|Read More
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER AND FIRST HALF OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKApyxMedical2025-12-12T19:44:09+00:00August 7, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF MINNIE BAYLOR-HENRY TO THE COMPANY’S BOARD OF DIRECTORSApyxMedical2025-12-12T19:44:31+00:00August 6, 2019|Read More
APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR NEXT-GENERATION J-PLASMA® PRECISE HANDPIECE DESIGNED FOR LAPAROSCOPIC SURGERYApyxMedical2025-12-12T19:44:53+00:00August 5, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES NEW ADDITIONS TO CLINICAL AND REGULATORY AFFAIRS TEAMSApyxMedical2025-12-12T19:45:15+00:00July 31, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF FOUR MEMBERS TO ITS MEDICAL ADVISORY BOARDApyxMedical2025-12-12T19:45:35+00:00July 15, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON AUGUST 7, 2019ApyxMedical2025-12-12T19:45:55+00:00July 2, 2019|Read More
APYX MEDICAL CORPORATION JOINS RUSSELL 3000® AND RUSSELL 2000® INDEXESApyxMedical2025-12-12T19:46:18+00:00July 1, 2019|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEApyxMedical2025-12-12T19:46:39+00:00June 4, 2019|Read More
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKApyxMedical2025-12-12T19:47:02+00:00May 8, 2019|Read More
APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOKApyxMedical2025-12-12T19:47:27+00:00April 1, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019ApyxMedical2025-12-12T19:47:50+00:00April 1, 2019|Read More
